Abbott clinical biochemical glucose test panel
Taiwan·Risk Class 2·ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.·Registered Jun 07, 2007 – Jun 07, 2027Active- Analysis ID
- 24f7e0b33f08effdb8a70e2252d41af3
- Customs Code
- DHA00601828305
- Manufacturer
- ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.
- Manufacturer Country
- Canada;;Germany
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- Quantify glucose in human serum, plasma, urine, or cerebrospinal fluid (CSF).
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- Contract manufacturing;; input
- Registration Date
- Jun 07, 2007
- Expiry Date
- Jun 07, 2027
Top companies providing products similar to "Abbott clinical biochemical glucose test panel"
Recently registered similar products
Access comprehensive regulatory information for Abbott clinical biochemical glucose test panel in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 24f7e0b33f08effdb8a70e2252d41af3 and manufactured by ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including ABBOTT LABORATORIES, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.